Product Information
BRIMONIDINE TARTRATE 0.1% DROP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $9.0594 per ML under NDC 62332074905. Its NADAC has been published 137 times since Feb 21, 2024.
FDA first approved this application on Aug 1, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332074905
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
BRIMONIDINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA216909FDA Approved
8/1/2023
TE Code
AB
On Market Since
8/1/2023
Pharmacological Classes
Price Statistics
The NADAC for BRIMONIDINE TARTRATE 0.1% DROP has been published 137 times since Feb 21, 2024, and over the history we have for it it has declined 70.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.0594 per ML |
|---|---|
| All-time high | $30.9975 (Mar 13, 2024) |
| All-time low | $9.0594 (Sep 23, 2026) |
| 52-week high | $15.3158 |
| 52-week low | $9.0594 |
| Median price | $15.3158 |
| Average price | $15.8595 |
| Largest weekly change | -35.2% (Apr 17, 2024) |
| Weeks tracked | 137 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Brimonidine Tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BRIMONIDINE TARTRATE 0.1% DROP?
The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE TARTRATE 0.1% DROP, manufactured by Alembic Pharmaceuticals Inc., is $9.0594 per ML (NDC 62332074905), effective Sep 30, 2026.
How has the price of BRIMONIDINE TARTRATE 0.1% DROP changed over time?
Over the history we have for it, the NADAC for BRIMONIDINE TARTRATE 0.1% DROP has declined 70.8%. It has been tracked across 137 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for BRIMONIDINE TARTRATE 0.1% DROP?
Since Feb 21, 2024, the NADAC for BRIMONIDINE TARTRATE 0.1% DROP has ranged from a low of $9.0594 (Sep 23, 2026) to a high of $30.9975 (Mar 13, 2024), with a median of $15.3158 per ML.
Are there cheaper alternatives to BRIMONIDINE TARTRATE 0.1% DROP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE TARTRATE 0.1% DROP, is $6.5539 per ML — about 28% below BRIMONIDINE TARTRATE 0.1% DROP.
Who manufactures BRIMONIDINE TARTRATE 0.1% DROP?
BRIMONIDINE TARTRATE 0.1% DROP (NDC 62332074905) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.